F. Binder-foucard, N. Bossard, P. Delafosse, A. Belot, A. Woronoff et al., Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique, pp.95-108, 2014.

N. Goutté, P. Sogni, N. Bendersky, J. Barbare, B. Falissard et al., Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country, Journal of Hepatology, vol.66, issue.3, pp.537-581, 2017.
DOI : 10.1016/j.jhep.2016.10.015

H. El-serag, Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma, Gastroenterology, vol.142, issue.6, pp.1264-1273, 2012.
DOI : 10.1053/j.gastro.2011.12.061

S. Bhoori and V. Mazzaferro, Current challenges in liver transplantation for hepatocellular carcinoma, Best Practice & Research Clinical Gastroenterology, vol.28, issue.5, pp.867-79, 2014.
DOI : 10.1016/j.bpg.2014.08.001

P. Bhangui, M. Allard, E. Vibert, D. Cherqui, G. Pelletier et al., Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma, Annals of Surgery, vol.264, issue.1, pp.155-63, 2016.
DOI : 10.1097/SLA.0000000000001442

M. Zimmerman, R. Ghobrial, M. Tong, J. Hiatt, A. Cameron et al., Recurrence of Hepatocellular Carcinoma Following Liver Transplantation, Archives of Surgery, vol.143, issue.2, pp.182-188, 1960.
DOI : 10.1001/archsurg.2007.39

A. Hollebecque, T. Decaens, E. Boleslawski, P. Mathurin, C. Duvoux et al., Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation, Gastroent??rologie Clinique et Biologique, vol.33, issue.5, pp.361-370, 2009.
DOI : 10.1016/j.gcb.2009.02.036

D. Samuel, M. Colombo, H. El-serag, R. Sobesky, and N. Heaton, Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, pp.6-13, 2011.

V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti et al., Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis, New England Journal of Medicine, vol.334, issue.11, pp.693-702, 1996.
DOI : 10.1056/NEJM199603143341104

J. Marsh and I. Dvorchik, Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, pp.693-699, 2003.

C. Duvoux, T. Decaens, F. Roudot-thoraval, S. Hadni-bresson, P. Wolf et al., Factors associated with recurrence after transplantation for hepatocellular carcinoma, Journal of Hepatology, vol.38, p.12, 2003.
DOI : 10.1016/S0168-8278(03)80449-X

F. Yao, L. Ferrell, N. Bass, J. Watson, P. Bacchetti et al., Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival, Hepatology, vol.33, issue.6, pp.1394-403, 2001.
DOI : 10.1053/jhep.2001.24563

C. Duvoux, ?. Roudot, F. Thoraval, T. Decaens, F. Pessione et al., Liver Transplantation for Hepatocellular Carcinoma: A Model Including ??-Fetoprotein Improves the Performance of Milan Criteria, Gastroenterology, vol.143, issue.4, pp.986-994, 2012.
DOI : 10.1053/j.gastro.2012.05.052

URL : https://hal.archives-ouvertes.fr/inserm-00865368

A. Notarpaolo, R. Layese, P. Magistri, M. Gambato, M. Colledan et al., Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC, Journal of Hepatology, vol.66, issue.3, pp.552-561, 2017.
DOI : 10.1016/j.jhep.2016.10.038

C. Costentin, G. Amaddeo, T. Decaens, K. Boudjema, P. Bachellier et al., Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models, Liver International, vol.12, issue.5, pp.717-743
DOI : 10.1053/jlts.2002.34879

F. Piñero, T. Baña, M. De-ataide, E. , H. Duque et al., Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America, Liver Int Off J Int Assoc Study Liver, 2016.

F. Yao, X. L. Bass, N. Kerlan, R. Ascher, N. Roberts et al., Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF-Expanded Criteria Based on Preoperative Imaging, American Journal of Transplantation, vol.7, issue.11, 2007.
DOI : 10.1053/jlts.2003.50227

V. Mazzaferro, J. Llovet, R. Miceli, S. Bhoori, M. Schiavo et al., Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, The Lancet Oncology, vol.10, issue.1, pp.35-43, 2009.
DOI : 10.1016/S1470-2045(08)70284-5

P. Clavien, M. Lesurtel, P. Bossuyt, G. Gores, B. Langer et al., Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report, The Lancet Oncology, vol.13, issue.1, pp.11-22
DOI : 10.1016/S1470-2045(11)70175-9

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417764

B. Hameed, N. Mehta, G. Sapisochin, J. Roberts, and F. Yao, Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, pp.945-51, 2014.

M. Samoylova, J. Dodge, F. Yao, and J. Roberts, Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, pp.937-981, 2014.

C. Toso, S. Asthana, D. Bigam, A. Shapiro, and N. Kneteman, Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatol Baltim Md, pp.832-840, 2009.

M. Fujiki, Y. Takada, Y. Ogura, F. Oike, T. Kaido et al., Significance of des-gammacarboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma, Am J Transplant Off J, 2009.

P. Salvalaggio, G. Felga, D. Axelrod, D. Guardia, B. Almeida et al., List and Liver Transplant Survival According to Waiting Time in Patients With Hepatocellular Carcinoma, American Journal of Transplantation, vol.19, issue.3, pp.668-77
DOI : 10.1016/j.jhep.2010.12.040

I. Bonadio, I. Colle, A. Geerts, P. Smeets, G. Berardi et al., Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience, Clinical Transplantation, vol.51, issue.Suppl 1, pp.425-458
DOI : 10.1159/000122598

R. Chaiteerakij, X. Zhang, B. Addissie, E. Mohamed, W. Harmsen et al., Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, pp.599-606, 2015.

A. Andreou, S. Gül, A. Pascher, W. Schöning, H. Al-abadi et al., Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma, HPB, vol.17, issue.2, pp.168-75, 2015.
DOI : 10.1111/hpb.12345

M. Fujioka, Y. Nakashima, O. Nakashima, and M. Kojiro, Immunohistologic study on the expressions of [alpha ]-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma, Hepatology, vol.34, issue.6, pp.1128-1162, 2001.
DOI : 10.1053/jhep.2001.29202

C. Liu, G. Xiao, L. Yan, B. Li, L. Jiang et al., Value of ??-fetoprotein in association with clinicopathological features of hepatocellular carcinoma, World Journal of Gastroenterology, vol.19, issue.11, pp.1811-1820, 2013.
DOI : 10.3748/wjg.v19.i11.1811

T. Yamashita, M. Forgues, W. Wang, J. Kim, Q. Ye et al., EpCAM and ??-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma, Cancer Research, vol.68, issue.5, pp.1451-61, 2008.
DOI : 10.1158/0008-5472.CAN-07-6013

URL : http://cancerres.aacrjournals.org/content/canres/68/5/1451.full.pdf

B. Brusset and T. Decaens, Refining Milan criteria: is the alpha-fetoprotein model ready to cross borders?, AME Medical Journal, vol.2, pp.116-116, 2017.
DOI : 10.21037/amj.2017.08.17

S. Bellentani and C. Tiribelli, The spectrum of liver disease in the general population: lesson from the Dionysos study, Journal of Hepatology, vol.35, issue.4, pp.531-538, 2001.
DOI : 10.1016/S0168-8278(01)00151-9

J. P. Fine and R. J. Gray, A Proportional Hazards Model for the Subdistribution of a Competing Risk, Journal of the American Statistical Association, vol.69, issue.446, pp.496-509, 1999.
DOI : 10.1093/biomet/69.1.239

E. Vibert, D. Azoulay, E. Hoti, S. Iacopinelli, D. Samuel et al., Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor, American Journal of Transplantation, vol.6, issue.2 Suppl 1, 2010.
DOI : 10.1111/j.1600-6143.2006.01509.x

T. Decaens, F. Roudot-thoraval, S. Hadni-bresson, C. Meyer, J. Gugenheim et al., Impact of UCSF criteria according to pre-and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, pp.1761-1770, 2006.

G. Otto, M. Schuchmann, M. Hoppe-lotichius, M. Heise, A. Weinmann et al., How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?, Journal of Hepatology, vol.59, issue.2, pp.279-84, 2013.
DOI : 10.1016/j.jhep.2013.04.006

M. Allard, M. Sebagh, A. Ruiz, C. Guettier, P. B. Vibert et al., Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?, Journal of Hepatology, vol.63, issue.1, pp.83-92
DOI : 10.1016/j.jhep.2015.01.023

F. Yao, N. Mehta, J. Flemming, J. Dodge, B. Hameed et al., Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatol Baltim Md, pp.1968-77, 2015.

R. Adam, P. Bhangui, E. Vibert, D. Azoulay, G. Pelletier et al., Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver, Annals of Surgery, vol.256, issue.6, pp.883-91, 2012.
DOI : 10.1097/SLA.0b013e318273bad0

P. Majno, F. Sarasin, G. Mentha, and A. Hadengue, Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis, Hepatology, vol.5, issue.4, pp.899-906, 2000.
DOI : 10.1053/he.2000.5763

D. Cherqui, A. Laurent, N. Mocellin, C. Tayar, A. Luciani et al., Liver Resection for Transplantable Hepatocellular Carcinoma, Annals of Surgery, vol.250, issue.5, pp.738-784, 2009.
DOI : 10.1097/SLA.0b013e3181bd582b

M. Landman, I. Feurer, C. Pinson, and D. Moore, Which is more cost???effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco???regional therapy for hepatocellular carcinoma within Milan criteria?, HPB, vol.13, issue.11, 2011.
DOI : 10.1111/j.1477-2574.2011.00355.x

S. Dharancy, Modification du système d'allocation des greffons pour le carcinome hépatocellulaire: c'est en cours! Hepato Gastro, p.38, 2016.